Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

What is the influence of long-term ursodeoxycholic acid therapy in patients with primary biliary cirrhosis?

Nature Clinical Practice Gastroenterology & Hepatology volume 4, pages 188–189 (2007)Cite this article

boxed-textter Borg PC et al. (2006) Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. Am J Gastroenterol 101: 2044–2050

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Poupon R et al. (1997) Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 113: 884–890

    Article  CAS  Google Scholar 

  2. Corpechot C et al. (2005) The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 128: 297–303

    Article  CAS  Google Scholar 

  3. Pares A et al. (2006) Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 130: 715–720

    Article  CAS  Google Scholar 

  4. Prince M et al. (2002) Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology 123: 1044–1051

    Article  Google Scholar 

  5. Angulo P et al. (1999) Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver 19: 115–121

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. VC Clark is a Gastroenterology Fellow, and C Levy is a Clinical Assistant Professor at the University of Florida, Gainesville, FL, USA.,

    Virginia C Clark & Cynthia Levy

Authors
  1. Virginia C Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cynthia Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cynthia Levy.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clark, V., Levy, C. What is the influence of long-term ursodeoxycholic acid therapy in patients with primary biliary cirrhosis?. Nat Rev Gastroenterol Hepatol 4, 188–189 (2007). https://doi.org/10.1038/ncpgasthep0741

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0741

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing